About Vikas
Vikas Sinha brings more than 30 years of experience in executive finance roles in the life sciences industry. He is a co-founder of ElevateBio, previously served as CFO, and now serves as on its Board of Directors and is Chair of the Audit Comittee. He is Chief Financial Officer of Scholar Rock.
Prior to ElevateBio, Vikas served as CFO of Alexion Pharmaceuticals for 11 years, where he was responsible for finance, business development, strategy, and IT. During his tenure as CFO, Alexion’s market cap grew from $600 million to more than $30 billion and revenue grew from zero to more than $3 billion.
Prior to joining Alexion, Vikas held various positions with Bayer AG in the United States, Japan, Germany, and Canada, including Vice President and CFO of Bayer Pharmaceuticals Corporation, U.S. and VP and CFO of Bayer Yakuhin Ltd., in Japan. He serves as an independent board member and Audit Committee Chair of Verona Pharma Inc. and serves as a board member of Orna Therapeutics.
Education and Accomplishments
Vikas serves as a member of ElevateBio Board of Directors and is Chair of the Audit Committee. Vikas received his MBA from the Asian Institute of Management, Manila, Philippines. He is a qualified Chartered Accountant and associate member of the Institute of Chartered Accountants of India and a Certified Public Accountant in the United States.
